Arkolith/Insider Trading/NMRA/Form 4

Aurora Daljit Singh

See RemarksNeumora Therapeutics, Inc. (NMRA) · full profile →Form 4 · filed May 30, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
16
0 non-derivative · 16 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2025Grant(A)138K——138K
May 28, 2025Grant(A)41K——41K
May 28, 2025Disposed to issuer(D)1.0M——0
May 28, 2025Disposed to issuer(D)195K——0
May 28, 2025Disposed to issuer(D)30K——0
May 28, 2025Disposed to issuer(D)72K——0
May 28, 2025Disposed to issuer(D)136K——0
May 28, 2025Disposed to issuer(D)208K——0
May 28, 2025Disposed to issuer(D)138K——0
May 28, 2025Disposed to issuer(D)41K——0
May 28, 2025Grant(A)1.0M——1.0M
May 28, 2025Grant(A)195K——195K
May 28, 2025Grant(A)30K——30K
May 28, 2025Grant(A)72K——72K
May 28, 2025Grant(A)208K——208K
May 28, 2025Grant(A)136K——136K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-079922) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML